Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

about

Kallikreins - The melting pot of activity and function

P2860

Q36563056-DB42317B-6D04-4778-A70C-AE82CE1672A0

P2860

Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

Item

http://www.wikidata.org/entity/Q38413737

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Kallikrein-related peptidases ...... : perspectives and challenges.

@en

type

Item

label

Kallikrein-related peptidases ...... : perspectives and challenges.

@en

prefLabel

Kallikrein-related peptidases ...... : perspectives and challenges.

@en

P1476

Kallikrein-related peptidases ...... r: perspectives and challenges

@en

P2093

Antonello Menghi

http://www.w3.org/2001/XMLSchema#string

Stefania Pellicori

http://www.w3.org/2001/XMLSchema#string

Vincenzo Formica

http://www.w3.org/2001/XMLSchema#string

Vittore Cereda

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Cancer statistics, 2014

Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues

Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

Causes and consequences of microRNA dysregulation in cancer

PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism

P304

929-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2015.1035708

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mario Roselli

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25858813

http://www.w3.org/2001/XMLSchema#string

Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

about

P2860

P2860

Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698